Search research articles
Contact Us
Filters
Showing results (1-10 of 63) with videos related to
Page
of 7
Sort By:
Clinical and Molecular Hepatology
|
January 18, 2026
New Insights into Antibody-Mediated NK Cell Immunity in Hepatitis B: Editorial on "Dissecting antibody-mediated NK cell effects reveals a cytotoxic CX3CR1⁺KLRC2⁻CD16hi subset linked to HBV outcomes"
Zuzana Macek Jilkova, Caroline Aspord
Journal of Autoimmunity
|
July 9, 2004
Early events in islets and pancreatic lymph nodes in autoimmune diabetes
Caroline Aspord, Sophie Rome, Charles Thivolet
Medecine Sciences : M/S
|
March 20, 2026
[Metabolic rewiring of dendritic cells to re-invigorate antitumor immunity]
Caroline Aspord, Camille Niveau, Philippe Saas
Cancers
|
September 23, 2020
Reply to Comment on "Jilkova, Z.M.; et al. Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges" <i>Cancers</i> 2019, <i>11</i>, 1554
Zuzana Macek Jilkova, Caroline Aspord, Thomas Decaens
Cancers
|
October 17, 2019
Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges
Zuzana Macek Jilkova, Caroline Aspord, Thomas Decaens
Cancers
|
May 16, 2023
Dendritic Cell Subsets in Melanoma: Pathophysiology, Clinical Prognosis and Therapeutic Exploitation
Eleonora Sosa Cuevas, Philippe Saas, Caroline Aspord
European Journal of Immunology
|
July 22, 2014
pDCs efficiently process synthetic long peptides to induce functional virus- and tumour-specific T-cell responses
Caroline Aspord, Claire Leloup, Sabine Reche, et al.
Immunology
|
May 14, 2024
Glycans in melanoma: Drivers of tumour progression but sweet targets to exploit for immunotherapy
Camille Niveau, Eleonora Sosa Cuevas, Philippe Saas, et al.
Cancer Immunology Research
|
April 30, 2014
Plasmacytoid dendritic cells support melanoma progression by promoting Th2 and regulatory immunity through OX40L and ICOSL
Caroline Aspord, Marie-Therese Leccia, Julie Charles, et al.
Oncoimmunology
|
April 5, 2014
Melanoma hijacks plasmacytoid dendritic cells to promote its own progression
Caroline Aspord, Marie-Therese Leccia, Julie Charles, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 63) with videos related to
Sort By:
Page
of 7
Clinical and Molecular Hepatology
|
January 18, 2026
New Insights into Antibody-Mediated NK Cell Immunity in Hepatitis B: Editorial on "Dissecting antibody-mediated NK cell effects reveals a cytotoxic CX3CR1⁺KLRC2⁻CD16hi subset linked to HBV outcomes"
Zuzana Macek Jilkova, Caroline Aspord
Journal of Autoimmunity
|
July 9, 2004
Early events in islets and pancreatic lymph nodes in autoimmune diabetes
Caroline Aspord, Sophie Rome, Charles Thivolet
Medecine Sciences : M/S
|
March 20, 2026
[Metabolic rewiring of dendritic cells to re-invigorate antitumor immunity]
Caroline Aspord, Camille Niveau, Philippe Saas
Cancers
|
September 23, 2020
Reply to Comment on "Jilkova, Z.M.; et al. Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges" <i>Cancers</i> 2019, <i>11</i>, 1554
Zuzana Macek Jilkova, Caroline Aspord, Thomas Decaens
Cancers
|
October 17, 2019
Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges
Zuzana Macek Jilkova, Caroline Aspord, Thomas Decaens
Cancers
|
May 16, 2023
Dendritic Cell Subsets in Melanoma: Pathophysiology, Clinical Prognosis and Therapeutic Exploitation
Eleonora Sosa Cuevas, Philippe Saas, Caroline Aspord
European Journal of Immunology
|
July 22, 2014
pDCs efficiently process synthetic long peptides to induce functional virus- and tumour-specific T-cell responses
Caroline Aspord, Claire Leloup, Sabine Reche, et al.
Immunology
|
May 14, 2024
Glycans in melanoma: Drivers of tumour progression but sweet targets to exploit for immunotherapy
Camille Niveau, Eleonora Sosa Cuevas, Philippe Saas, et al.
Cancer Immunology Research
|
April 30, 2014
Plasmacytoid dendritic cells support melanoma progression by promoting Th2 and regulatory immunity through OX40L and ICOSL
Caroline Aspord, Marie-Therese Leccia, Julie Charles, et al.
Oncoimmunology
|
April 5, 2014
Melanoma hijacks plasmacytoid dendritic cells to promote its own progression
Caroline Aspord, Marie-Therese Leccia, Julie Charles, et al.
Page
of 7